A new study published in this week's Journal of the American Medical Association (JAMA) finds that people with mild intestinal inflammation and a sensitivity to gluten have a greater risk of death even amongst patients who do not have severe symptoms.This means you could have only mild issues and perhaps not even test positive for celiac disease, yet still have a greater risk of death.
For the study, Swedish researchers examined tissue biopsies collected from 46,121 patients in Sweden between 1969 and 2008. Amongst the samples, they found 29,096 patients with celiac disease, 13,306 with inflammation of the small intestines and an additional 3,719 with latent celiac disease. For those of you who don't know, latent celiac refers to patients who have celiac disease antibodies present in their blood, but do not show signs of damage to their intestines.
After a median of 7.2 years follow-up, the researchers determined that the risk of death increased by 75% for patients with mild intestinal inflammation, 35% for patients with latent celiac or gluten sensitivity and 30% for patients with diagnosed celiac disease. Amongst the patients with celiac disease, the most common causes of death were cancer and cardiovascular disease.
In an editorial accompanying the article, Dr. Peter Green of the Celiac Center at Columbia University Medical Center said the most interesting finding was that about patients with latent celiac disease or gluten sensitivity, largely because the issue has received little attention in the United States.
He adds that there is "increasing evidence for [gluten sensitivity] presence in patients with various neurological disorders and psychiatric problems. The study....reinforces the importance of celiac disease as a diagnosis that should be sought by physicians. It also suggests that more attention should be given to the lesser degrees of intestinal inflammation and gluten sensitivity."

To
highlight the importance of education on the issue, on December 3,
2007, CNN Newsroom Anchor Heidi Collins addressed
an audience of 12,000 in-hospital pharmacists at the American Society
of Health System Pharmacists Mid-Year Clinical Meeting. Heidi spoke
about spending Christmas Eve in a hospital emergency room. Her six-year-old son, who has celiac disease, had a horrible infection and
desperately needed a course of antibiotics. At 11:00pm on Christmas
Eve, no one at the pharmaceutical companies was available to tell the
doctors if there was gluten in the pills. 